MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Elimination of STN stimulation-induced dyskinesias with ViM DBS

    D. Shah-Zamora, J. Karl, L. Verhagen (Chicago, USA)

    Objective: To describe effects of thalamic deep brain stimulation (DBS) on severe dyskinesias induced by subthalamic nucleus (STN) DBS in a person with Parkinson’s disease…
  • 2022 International Congress

    Activity and sleep associated with changes in glymphatic imaging-markers in Parkinson Disease patients enrolled in 3-month exercise program

    J. Elenberger, J. Eisma, K. Hett, A. Song, C. Mcknight, Y. Yan, H. Kang, M. Donahue, D. Claassen, C. Considine (Nashville, USA)

    Objective: To investigate whether intensity of activity and quality of sleep during a 3-month exercise program for patients with Parkinson Disease (PD) are associated with…
  • 2022 International Congress

    Frequency dependent interindividual variability of the deep brain stimulation effect on upper-limb bradykinesia

    P. Dorin, D. Brogle, S. Hägele-Link, M. Krüger, G. Kägi, F. Brugger (St. Gallen, Switzerland)

    Objective: To demonstrate that there are interindividual differences in the response of upper limb bradykinesia to subthalamic deep brain stimulation (STN-DBS) in patients with Parkinson’s…
  • 2022 International Congress

    Relative bioavailability of levodopa administered as a subcutaneous infusion with ND0612 versus oral immediate-release levodopa/carbidopa tablets

    L. Adar, N. Vostokova (Rehovot, Israel)

    Objective: To determine the relative bioavailability of levodopa when administered as a subcutaneous (SC) levodopa/carbidopa (LD/CD) infusion with ND0612 versus levodopa derived from oral immediate-release…
  • 2022 International Congress

    Non-motor signs in essential tremor and essential tremor-plus syndromes

    A. Nasri, A. Rekik, S. Mrabet, Y. Abida, A. Gharbi, A. Souissi, A. Gargouri, I. Kacem, R. Gouider (Mannouba, Tunisia)

    Objective: To investigate the non-motor profiles of essential tremor (ET) and essential tremor-plus (ET-plus) syndromes. Background: The recently established concept of differentiating ET from ET-plus…
  • 2022 International Congress

    Genetic contribution to domain specific cognitive decline

    V. Livneh, N. Omer, N. Giladi, T. Gurevich, A. Bar-Shira, M. Gana-Weisz, O. Goldstein, J. Shirvan, J. Cedarbaum, A. Orr-Urtreger, R. Alcalay, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: To assess differences in cognitive domains  between patients with Parkinson’s disease with the LRRK2 and GBA risk mutations Background: Most patients with PD show…
  • 2022 International Congress

    Neurovascular and immune determinants of selective vulnerability of dopaminergic neurons in Parkinson’s Disease

    T. Balzano, N. Lopez Gonzalez-Del-Rey, N. Esteban-Garcia, A. Reinares-Sebastian, I. Trigo-Damas, JA. Pineda-Pardo, C. Cavada, JA. Obeso, J. Blesa (Mostoles, Spain)

    Objective: We aimed to investigate the contribution of glial cells activation and immune cells infiltration in the selective vulnerability of dopaminergic neurons within the midbrain…
  • 2022 International Congress

    Decrease of striatal activity during the execution of a everyday-life motor habits in early Parkinson’s disease.

    P. Guida, M. Michiels, M. H Monje, J. Obeso, I. Obeso (Móstoles, Spain)

    Objective: The aim of this study was to investigate the influence of dopaminergic cell loss on motor habitual behaviour, by comparison between newly diagnosed Parkinson’s…
  • 2022 International Congress

    Wearing-off Questionnaire as a quantify measure of Wearing-off

    CE. Mantese, M. Medeiros, A. Schumacher-Schuh, CR. Rieder (Porto Alegre, Brazil)

    Objective: To aim for the correlation of 19- items Wearing Off Questionnaire (WOQ-19) positive items and MDS-UPDRS IV. Background: Parkinson's disease (PD) has a well…
  • 2022 International Congress

    Real-world evidence and feasibility of telemedicine for Parkinson’s disease

    G. Rigas, N. Kostikis, N. Tachos, E. Kontogiannis, E. Kostoulas, A. Bousis, S. Konitsiotis, D. Fotiadis (Ioannina, Greece)

    Objective: This work aims to provide real-world evidence for the feasibility of telemedicine in Parkinson’s disease (PD). Adherence data presented pertain to patients paying out…
  • « Previous Page
  • 1
  • …
  • 110
  • 111
  • 112
  • 113
  • 114
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley